The genae
difference
Expertise
Innovation
Scope
Partnership
Value
genae’s expertise covers a broad range of therapeutic areas. The knowledge and understanding of the specific area of your therapy or device ensures compliance and facilitates in the actual conduct of your trial.
Your advantage of working with genae is captured in our extensive experience in the central coordination and logistics of clinical research projects.
genae’s mission is to improve health and quality of life by innovating and accelerating high quality research – with a zealous dedication to safety and ethics.
With local anchoring, we aim at accelerating high-quality and cost-contained recruitment and execution of your global medical device trials.
Read more

genae updates  

 
 

Insourcing or Outsourcing - Do the sums add up?

10 May 2016

Insourcing or outsourcing in clinical trials is a late-breaking topic. Despite other branches of trade such as the automotive industry where large companies are experiencing a comeback of insourcing, the conduct of clinical trials are mostly outsourced to contract research organizations (CROs). This paper tackles the benefits and challenges of both approaches and sheds light on what to take into consideration when outsourcing your clinical trial to a CRO.

Continue reading
 

Join our session on clinical trials at EuroPCR

21 April 2016

Join our session 'Planned and ongoing clinical trials: a status update from genae' at EuroPCR on Wednesday 18 May 2016, 13:35-14:35.

The session will take place in room 343 and will include guest speakers William F. Fearon, MD; Marianne Brodmann, MD; Mathias Vrolix, MD; Jozef Bartunek, MD and Marina Urena-Alcazar, MD.

Attend this session if you want

  • To be updated on planned or ongoing clinical trials that may change our future practice
  • To gain in depth understanding of trial design and execution
  • To learn about upcoming milestones for trial recruitment, analysis and presentation plan

Continue reading
 

genae Appoints Chief Medical Officer

26 April 2016

genae, a Contract Research Organization (CRO) and services provider for the medical industries, announced today the appointment of Prof. Dr. Jörn Balzer to the role of Chief Medical Officer. Prof. Balzer's responsibilities will include all clinical, safety and risk management related to genae's research services.

"We feel privileged and honored with the acceptance of Prof. Balzer to join our team," said Bart Segers, CEO at genae. "Prof. Balzer's impressive and extensive background make him a perfect fit for the genae team, as his extensive clinical and research expertise will play a key role in helping us to achieve our goals and strategic priorities."

Prof. Balzer is Head Physician and Medical Director at the Katholische Klinikum Mainz, Germany. Previously, he was Assistant Medical Director at the Klinikum der Johann Wolfgang Goethe Universität in Frankfurt Am Main, Director at the Universitätsklinikum des Saarlandes in Homburg /Saar, and Intern at the Charité Campus Virchow Klinikum in Berlin. His scientific and research work is illustrated by peer-reviewed publications and presentations during international congresses and symposia.

About the genae  group

genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. genae is a full service CRO and services provider for the medical industries and aims at improving health and quality of life by innovating and accelerating high quality research. The group's Quality Management System has been tested rigorously and continues to pass regulatory and sponsor's audits and inspections.

genae associates nv is a privately held company with principal offices in Antwerp, Belgium and is part of the genae group, the medical device CRO.

Continue reading